Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...